RecruitingNCT06325709
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
PHASE1 · PHASE2 · 15 planned enrolment
- Countries listed
- 1
- Registry update
- August 13, 2026
immortal.lifeTrial registrations containing the exact intervention label Plerixafor.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · PHASE2 · 15 planned enrolment